C1q nephropathy: features at presentation and outcome
- PMID: 15827744
- DOI: 10.1007/s00467-004-1810-8
C1q nephropathy: features at presentation and outcome
Abstract
The study population comprised all 20 patients followed since 1990 through December 2004 at the Le Bonheur Children's Medical Center with diagnosis of C1q nephropathy (55% boys; 60% African Americans). All were aged under 18 years at biopsy (mean 11.2 years, 65% aged 11 or over); the youngest presented at age 10 months and progressed to end-stage renal disease at 14 months. None had clinical or laboratory features of systemic lupus erythematosis or membranoproliferative glomerulonephritis. Clinical features assessed at diagnosis were age, gender, blood pressure, history of macroscopic hematuria, urinary protein to creatinine ratio, serum creatinine, estimated glomerular filtration rate, renal histology, and pattern for immunofluorescent reactants. At the time of biopsy 40% had nephrotic syndrome and 30% nephrotic range proteinuria without nephrotic syndrome. Three patients with nephrotic syndrome also had chronic renal insufficiency at diagnosis. The most common histological feature was focal segmental glomerulosclerosis in 40%, but 30% had minimal change lesion. Four patients, all with nephrotic syndrome at diagnosis, progressed to end-stage renal disease. Of the 12 patients not presenting with nephrotic syndrome, none had chronic renal insufficiency at last follow-up. Kidney survival was 94% and 78% at 1 and 5 years, respectively, in all patients and 88% and 49% in those presenting with nephrotic syndrome.
Comment in
-
C1q nephropathy with asymptomatic urine abnormalities.Pediatr Nephrol. 2005 Nov;20(11):1669-70. doi: 10.1007/s00467-005-2024-4. Epub 2005 Aug 16. Pediatr Nephrol. 2005. PMID: 16133042
Similar articles
-
C1q nephropathy: a variant of focal segmental glomerulosclerosis.Kidney Int. 2003 Oct;64(4):1232-40. doi: 10.1046/j.1523-1755.2003.00218.x. Kidney Int. 2003. PMID: 12969141
-
Pathology, clinical presentations, and outcomes of C1q nephropathy.J Am Soc Nephrol. 2008 Nov;19(11):2237-44. doi: 10.1681/ASN.2007080929. Epub 2008 Jul 23. J Am Soc Nephrol. 2008. PMID: 18650484 Free PMC article.
-
C1Q nephropathy in children.Pediatr Nephrol. 2005 Dec;20(12):1756-61. doi: 10.1007/s00467-005-2040-4. Epub 2005 Oct 25. Pediatr Nephrol. 2005. PMID: 16247648
-
The expanding spectrum of renal diseases associated with antiphospholipid syndrome.Am J Kidney Dis. 2003 Jun;41(6):1205-11. doi: 10.1016/s0272-6386(03)00352-4. Am J Kidney Dis. 2003. PMID: 12776272 Review.
-
Recent insights into the pathogenesis of nephrotic syndrome.Minerva Med. 2013 Jun;104(3):333-47. Minerva Med. 2013. PMID: 23748287 Review.
Cited by
-
Do C1q or IgM nephropathies predict disease severity in children with minimal change nephrotic syndrome?Pediatr Nephrol. 2014 Jan;29(1):67-74. doi: 10.1007/s00467-013-2551-3. Epub 2013 Jul 13. Pediatr Nephrol. 2014. PMID: 23852271
-
C1q nephropathy: a true immune complex disease or an immunologic epiphenomenon?NDT Plus. 2009 Aug;2(4):285-91. doi: 10.1093/ndtplus/sfp055. Epub 2009 May 9. NDT Plus. 2009. PMID: 25984017 Free PMC article.
-
C1q nephropathy in adults is a form of focal segmental glomerulosclerosis in terms of clinical characteristics.PLoS One. 2019 Apr 19;14(4):e0215217. doi: 10.1371/journal.pone.0215217. eCollection 2019. PLoS One. 2019. PMID: 31002691 Free PMC article.
-
A single-center study of C1q nephropathy in children.Pediatr Nephrol. 2009 Jan;24(1):77-82. doi: 10.1007/s00467-008-0939-2. Epub 2008 Aug 8. Pediatr Nephrol. 2009. PMID: 18688655
-
C1q nephropathy with asymptomatic urine abnormalities.Pediatr Nephrol. 2005 Nov;20(11):1669-70. doi: 10.1007/s00467-005-2024-4. Epub 2005 Aug 16. Pediatr Nephrol. 2005. PMID: 16133042
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical